Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Other Accumulated Expenses (2024 - 2025)

Historic Other Accumulated Expenses for Mangoceuticals (MGRX) over the last 2 years, with Q3 2025 value amounting to $160684.0.

  • Mangoceuticals' Other Accumulated Expenses fell 5715.09% to $160684.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $160684.0, marking a year-over-year decrease of 5715.09%. This contributed to the annual value of $373000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Mangoceuticals' Other Accumulated Expenses is $160684.0, which was down 5715.09% from $160684.0 recorded in Q2 2025.
  • Over the past 5 years, Mangoceuticals' Other Accumulated Expenses peaked at $400000.0 during Q2 2024, and registered a low of $160684.0 during Q2 2025.